Women in ADRD: Addressing Disparities in Diagnosis and Care

Tamlyn J Watermeyer*, The Female Brain & Endocrine Research (FemBER) Consortium

*Corresponding author for this work

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Women account for two-thirds of Alzheimer's disease cases worldwide, yet remain underrepresented in many research cohorts and underserved in clinical pathways. This presentation explores the intersecting biological, sociocultural, and systemic drivers that create disparities in the diagnosis and care of women with Alzheimer's disease and related dementias (ADRD). Drawing on recent international work, I will highlight how cumulative stress, hormonal transitions, caregiver burden, and diagnostic bias compound risk and delay intervention in women—particularly among Black, Indigenous, and Global South populations. I will argue for a reorientation of dementia diagnosis and care models that are not only sex-informed but equity-driven. Finally, I propose a roadmap for inclusive research design, community-based detection tools, and translational pathways that centre the biological as well as lived experiences of women across the lifespan—ensuring we diagnose earlier, care better, and prevent more equitably.
Original languageEnglish
Article numbere096010
Number of pages1
JournalAlzheimer's and Dementia
Volume21
Issue numberS6
Early online date23 Dec 2025
DOIs
Publication statusPublished - Dec 2025
EventTechnology and Dementia Preconference 2025 - The Westin Harbour Castle, Toronto, Canada
Duration: 26 Jul 202526 Jul 2025

Keywords

  • Alzheimer Disease/diagnosis
  • Caregivers
  • Dementia/diagnosis
  • Female
  • Healthcare Disparities
  • Humans
  • Public Health

Fingerprint

Dive into the research topics of 'Women in ADRD: Addressing Disparities in Diagnosis and Care'. Together they form a unique fingerprint.

Cite this